Top Abstract Purchase Related
Home
>
Node
>
Subnode

Study on the immunogenicity of adeno-vector vaccine against H5N1 influenza a virus

Zhang, X.-g.; Li, K.-b.; Ma, J.; Wang, N.-f.; Zhang, X.-m.; Sang, Y.-h.; Dong, J.; Xu, H.; Zeng, Y.

Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(2): 97-99

2009

ISSN/ISBN: 1003-9279
PMID: 20104746
Document Number: 628851
To construct adenovirus vector vaccine against H5N1 influenza virus and study on the immunogenicity. In this study, we amplified hemagglutinin (HA) gene sequence of H5N1 influenza virus (A/Anhui/1/2005), then constructed an adenovirus vector vaccine (Adv-HA), followed by tests in BALB/c mice for the immunogenicity with the vaccine and immunization strategies. The recombinate Adv-HA vaccine could effectively induce both humoral and cellular immunity against human H5N1 influenza virus. The Adv-HA vaccination against H5N1 influenza is a potential strategy and worthy of further investigation.

Document emailed within 1 workday
Secure & encrypted payments

Mehendale, S.; Sahay, S.; Thakar, M.; Sahasrabuddhe, S.; Kakade, M.; Shete, A.; Shrotri, A.; Spentzou, A.; Tarragona, T.; Stevens, G.; Kochhar, S.; Excler, J.L.; Fast, P.; Paranjape, R. 2010: Safety and immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India Indian Journal of Medical Research 132: 168-175
Huan, L-Fang.; Yao, L-Hong.; Chen, A-Jun.; Cheng, C-Sheng.; Jia, R-Qing.; Tian, Q.; Bo, H.; Guo, J-Qiang.; Wang, M.; Shu, Y-Long.; Zhang, Z-Qing. 2007: Construction and immunogenicity study of DNA vaccine expressing human H5N1 influenza virus hemagglutinin Bing du Xue Bao 23(5): 366-370
Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952
Arai, Y.; Kubo, T.; Fushiki, S.; Mazda, O.; Nakai, H.; Iwaki, Y.; Imanishi, J.; Hirasawa, Y. 2000: Gene delivery to human chondrocytes by an adeno associated virus vector Journal of Rheumatology 27(4): 979-982
Shi, Z.; Fan, L.; Qiang, H.; Tang, Y.; Wang, K.; Dang, X. 2010: Study on biological activity of recombinant adeno-associated virus vector co-expressing human vascular endothelial growth factor 165 and human bone morphogenetic protein 7 genes in vitro Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(4): 415-419
Fan, D.; Shen, Y.; Kang, D.; Nakano, I.; Ozawa, K. 2001: Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes Chinese Medical Journal 114(12): 1276-1279
Koppold, B.; Sauer, G.; Büning, H.; Hallek, M.; Kreienberg, R.; Deissler, H.; Kurzeder, C. 2005: Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector International Journal of Oncology 26(1): 95-101
Li, H.-H.; Zhang, S.-M.; Fang, S.-Y.; Chen, C.-L.; Luo, Y.-D.; Guan, Y.; Wang, D.-W.; Xiao, X. 2003: Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice Zhonghua Yi Xue Za Zhi 83(17): 1513-1516
Berezin, V.E.; Zaĭdes, V.M.; Isaeva, E.S.; Zhdanov, V.M. 1985: Immunogenicity of a subunit influenza vaccine in experiments on animals Voprosy Virusologii 30(2): 166-174
Koblin, B.A.; Casapia, M.; Morgan, C.; Qin, L.; Wang, Z.M.; Defawe, O.D.; Baden, L.; Goepfert, P.; Tomaras, G.D.; Montefiori, D.C.; McElrath, M.J.; Saavedra, L.; Lau, C.-Y.; Graham, B.S. 2011: Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial PLOS one 6(9): E24517
Zuccotti, G.V.; Cucchi, C.; Sala, D.; Giovannini, M. 2002: Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children Acta Paediatrica 91(4): 486; Author Reply 487
Zuccotti, G.V.; Cucchi, C.; Sala, D.; Giovannini, M. 2002: Immunogenicity and safety of a virosomal influenza vaccine in HIV-infected children Acta Paediatrica 91(4): 486; Author Reply 487
Erofeeva, M.K.; Mel'nikov, S.I.; Semchenko, A.V.; Korovkin, S.A.; Nikonorov, I.I.; Maksakova, V.L.; Voĭtsekhovskaia, E.M.; Erman, E.S.; Gonchar, V.V.; Pozdeev, V.K.; Drinevskiĭ, V.P. 2010: Clinical trial of safety and immunogenicity of new influenza vaccine Grifor in children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 55-59
Ramanathan, V.D.; Kumar, M.; Mahalingam, J.; Sathyamoorthy, P.; Narayanan, P.R.; Solomon, S.; Panicali, D.; Chakrabarty, S.; Cox, J.; Sayeed, E.; Ackland, J.; Verlinde, C.; Vooijs, D.; Loughran, K.; Barin, B.; Lombardo, A.; Gilmour, J.; Stevens, G.; Smith, M.S.; Tarragona-Fiol, T.; Hayes, P.; Kochhar, S.; Excler, J.-L.; Fast, P. 2009: A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers Aids Research and Human Retroviruses 25(11): 1107-1116
Gao, B.-a.; Xiong, W.-n.; Xu, Y.-j.; Zhang, Z.-x.; Cao, Y.; Tang, Y.-j.; Ye, T.; Du, C.-l. 2006: Effects of recombinant adeno-virus vector carrying interleukin-5 antisense on the expression of interleukin-5 mRNA and protein in CD4+ T lymphocytes of asthmatic rats Zhonghua Nei Ke Za Zhi 45(4): 298-301
Thongcharoen, P.; Auewarakul, P.; Hutagalung, Y.; Ong, G.; Gillard, P.; Drame, M.; Bock, H.L. 2011: Cross-clade immunogenicity and antigen-sparing with an AS03(A)-adjuvanted prepandemic influenza vaccine in a Thai population Journal of the Medical Association of Thailand 94(8): 916-926
Sandrini, M.C.; Pregliasco, F.; Mensi, C.; Giardini, G.; Lucchi, T.; Santambrogio, D.; Annoni, G.; Vergani, C. 1997: Immunogenicity and efficacy field evaluation (1994-1995 season) of influenza vaccine in a noninstitutionalized elderly population Annali di igiene: medicina preventiva e di comunita 9(5): 373-379
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480
van der Leek, M.L.; Feller, J.A.; Sorensen, G.; Isaacson, W.; Adams, C.L.; Borde, D.J.; Pfeiffer, N.; Tran, T.; Moyer, R.W.; Gibbs, E.P. 1994: Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63 Veterinary Record 134(1): 13-18